SPOP mutations promote p62/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer

Qing Shi1,2, Xiaofeng Jin3, Pingzhao Zhang4

  • 1State Key Laboratory of Genetic Engineering, MOE Engineering Research Center of Gene Technology, Shanghai Engineering Research Center of Industrial Microorganisms, School of Life Sciences, Fudan University, Shanghai, 200438, China.

Insights

SPOP protein regulates autophagy and oxidative stress response by modifying p62. SPOP mutations in prostate cancer disrupt this, promoting tumor growth via increased autophagy and Nrf2 activity.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Cancer Research

Background:

  • p62/SQSTM1 is a crucial autophagy receptor and stress-response scaffold protein implicated in neurodegenerative diseases and cancer.
  • Mutations in SPOP, an E3 ubiquitin ligase adapter, are common in prostate cancer (PCa), but their role in tumorigenesis is unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which SPOP mutations contribute to prostate cancer development.
  • To investigate the interaction between SPOP, p62, and the Nrf2 pathway in PCa.

Main Methods:

  • Investigated the ubiquitination of p62 by SPOP in vitro and in cellulo.
  • Assessed the impact of SPOP-mediated p62 ubiquitination on p62 function, autophagy, and Nrf2 pathway activation.
  • Analyzed the function of PCa-associated SPOP mutants.

Main Results:

  • Cytoplasmic SPOP induces non-degradative ubiquitination of p62, suppressing autophagy and Nrf2-mediated antioxidant gene expression.
  • PCa-associated SPOP mutants fail to ubiquitinate p62, leading to enhanced autophagy and redox response.
  • SPOP mutations promote PCa tumorigenesis by dysregulating p62-mediated autophagy and Nrf2 signaling.

Conclusions:

  • SPOP acts as a negative regulator of p62-dependent autophagy and Nrf2 activation.
  • Dysfunctional SPOP in PCa promotes oncogenesis through enhanced autophagy and redox signaling.
  • Targeting autophagy and Nrf2 pathways may offer therapeutic strategies for SPOP-mutated prostate cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K